{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:14:13Z","timestamp":1794651253120,"version":"4.9.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6 Part 1","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1097\/01.ju.0000127752.41749.a4","type":"journal-article","created":{"date-parts":[[2004,5,3]],"date-time":"2004-05-03T08:00:44Z","timestamp":1083571244000},"page":"2396-2403","source":"Crossref","is-referenced-by-count":116,"title":["DOES BLADDER PRESERVATION (AS A SURGICAL PRINCIPLE) LEAD TO RETAINING BLADDER FUNCTION IN BLADDER\/PROSTATE RHABDOMYOSARCOMA? RESULTS FROM INTERGROUP RHABDOMYOSARCOMA STUDY IV"],"prefix":"10.1097","volume":"171","author":[{"given":"CAROLA","family":"ARNDT","sequence":"first","affiliation":[{"name":"From the Mayo Clinic, Rochester, Minnesota (CA, DR), Duke University Medical Center, Durham, North Carolina (PPB), M.D. Anderson Cancer Center, Houston, Texas (RBR), University of Nebraska Medical Center, Omaha, Nebraska (FU), Stanford University Medical Center, Stanford (SD) and the Soft Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID","family":"RODEBERG","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic, Rochester, Minnesota (CA, DR), Duke University Medical Center, Durham, North Carolina (PPB), M.D. Anderson Cancer Center, Houston, Texas (RBR), University of Nebraska Medical Center, Omaha, Nebraska (FU), Stanford University Medical Center, Stanford (SD) and the Soft Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PHILIP P.","family":"BREITFELD","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic, Rochester, Minnesota (CA, DR), Duke University Medical Center, Durham, North Carolina (PPB), M.D. Anderson Cancer Center, Houston, Texas (RBR), University of Nebraska Medical Center, Omaha, Nebraska (FU), Stanford University Medical Center, Stanford (SD) and the Soft Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. BEVERLY","family":"RANEY","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic, Rochester, Minnesota (CA, DR), Duke University Medical Center, Durham, North Carolina (PPB), M.D. Anderson Cancer Center, Houston, Texas (RBR), University of Nebraska Medical Center, Omaha, Nebraska (FU), Stanford University Medical Center, Stanford (SD) and the Soft Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRED","family":"ULLRICH","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic, Rochester, Minnesota (CA, DR), Duke University Medical Center, Durham, North Carolina (PPB), M.D. Anderson Cancer Center, Houston, Texas (RBR), University of Nebraska Medical Center, Omaha, Nebraska (FU), Stanford University Medical Center, Stanford (SD) and the Soft Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SARAH","family":"DONALDSON","sequence":"additional","affiliation":[{"name":"From the Mayo Clinic, Rochester, Minnesota (CA, DR), Duke University Medical Center, Durham, North Carolina (PPB), M.D. Anderson Cancer Center, Houston, Texas (RBR), University of Nebraska Medical Center, Omaha, Nebraska (FU), Stanford University Medical Center, Stanford (SD) and the Soft Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1097\/01.ju.0000127752.41749.a4_bib1","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1200\/JCO.1995.13.8.2123","article-title":"Biology and therapy of pediatric rhabdomyosarcoma","volume":"13","author":"Pappo","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ssu.2980090610","article-title":"Bladder\/prostate rhabdomyosarcoma: results of the multi-institutional trials of the intergroup rhabdomyosarcoma study","volume":"9","author":"Hays","year":"1993","journal-title":"Semin Surg Oncol"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/1097-0142(19821015)50:8<1472::AID-CNCR2820500805>3.0.CO;2-Y","article-title":"Bladder and prostatic tumors in the intergroup rhabdomyosarcoma study (IRS-I): results of therapy","volume":"50","author":"Hays","year":"1982","journal-title":"Cancer"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib4","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","article-title":"Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease","volume":"19","author":"Crist","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0360-3016(01)01709-6","article-title":"Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma\u2014a report from the IRSG","volume":"51","author":"Donaldson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib6","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/1097-0142(19930401)71:7<2387::AID-CNCR2820710734>3.0.CO;2-A","article-title":"Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder and prostate. A report from the Intergroup Rhabdomyosarcoma Study Committee","volume":"71","author":"Raney","year":"1993","journal-title":"Cancer"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00043426-199502000-00008","article-title":"Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee","volume":"17","author":"Hays","year":"1995","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib8","first-page":"423","article-title":"Retention of functional bladders among patients with vesical\/prostatic sarcomas in the Intergroup Rhabdomyosarcoma Studies (IRS) (1972\u20131990)","volume":"19","author":"Hays","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0022-3468(05)80004-1","article-title":"Partial cystectomy in the management of rhabdomyosarcoma of the bladder: a report from the intergroup rhabdomyosarcoma study","volume":"25","author":"Hays","year":"1990","journal-title":"J Pediatr Surg"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0022-3468(96)90092-5","article-title":"The argument for conservative, delayed surgery in the management of prostatic rhabdomyosarcoma","volume":"31","author":"Lobe","year":"1996","journal-title":"J Pediatr Surg"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<573::AID-MPO10>3.0.CO;2-7","article-title":"Organ-preserving management of rhabdomyosarcoma of the prostate and bladder in children","volume":"29","author":"Silvan","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.1997.15.1.69","article-title":"Preservation of the bladder in patients with rhabdomyosarcoma","volume":"15","author":"Heyn","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1097\/01.ju.0000127752.41749.a4_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00043426-200003000-00005","article-title":"Presence of well-differentiated rhabdomyoblasts at the end of therapy for pelvic rhabdomyosarcoma: implications for the outcome","volume":"22","author":"Ortega","year":"2000","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705622057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705622057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1097\/01.ju.0000127752.41749.a4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:11:59Z","timestamp":1651212719000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1097\/01.ju.0000127752.41749.a4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":13,"journal-issue":{"issue":"6 Part 1","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1097\/01.ju.0000127752.41749.a4"],"URL":"https:\/\/doi.org\/10.1097\/01.ju.0000127752.41749.a4","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}